Global HPV Testing Market 2016-2020

  • ID: 4013358
  • Report
  • Region: Global
  • 80 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BD
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • IncellDx
  • MORE
About HPV Testing

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

Covered in This Report:
The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The Market is Divided into the Following Segments Based on Geography:
- Americas
- APAC
- EMEA

Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors:
- Abbott Laboratories
- BD
- Roche Diagnostics
- Qiagen

Other Prominent Vendors:
- Arbor Vita
- Breakspear Medical
- Cepheid
- DAAN Gene
- DiaCarta
- Delphi Bioscience
- Fujirebio Diagnostics
- Genera Biosystems
- IncellDx
- OralDNA Labs
- Seegene
- SoloPap
- Trovagene

Market Drivers:
- Early detection of cervical cancer to prevent the growing prevalence
- For a full, detailed list, view the full report

Market challenges:
- Pap test: Alternative diagnostic tests for cervical cancer screening
- For a full, detailed list, view the full report

Market Trends:
- Expansion of companies in key markets
- For a full, detailed list, view the full report

Key Questions Answered in This Report:
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BD
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • IncellDx
  • MORE
Part 01: Executive summary
  • Highlights
Part 02: Scope of the report
  • Market overview
  • Top-vendor offerings
Part 03: Market research methodology
  • Research methodology
  • Economic indicators
Part 04: Introduction
  • Key market highlights
  • Cervical cancer diagnosis by HPV testing
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product
  • Global HPV testing market by systems
  • Global HPV testing market by consumables
Part 07: Market segmentation by end-user
  • Hospitals
  • Clinical diagnostic laboratories
  • Physicians' office laboratories
Part 08: Geographical segmentation
  • HPV testing market in Americas
  • HPV testing market in EMEA
  • HPV testing market in APAC
Part 09: Market drivers
  • Early detection of cervical cancer to prevent the growing prevalence
  • Paradigm shift toward use of HPV home-testing kits
  • Reimbursements for HPV tests
Part 10: Impact of drivers

Part 11: Market challenges
  • Pap test: Alternative diagnostic test for cervical cancer screening
  • Limited number of health clinics and healthcare settings in developing countries
  • Lack of uniformity in screening policies
Part 12: Impact of drivers and challenges

Part 13: Market trends
  • Expansion of companies in key markets
  • Co-testing with HPV and Pap tests
  • Development of mRNA HPV test
Part 14: Vendor landscape
  • Competitive landscape analysis
Part 15: Key vendor analysis
  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen
  • Hologic
  • Other prominent vendors
Part 16: Appendix
  • List of abbreviations
Part 17: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Market dynamics: Global HPV testing market
Exhibit 03: Global HPV testing market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global HPV testing market by product 2015 and 2020
Exhibit 06: Market overview: Global HPV testing market by systems
Exhibit 07: Global HPV testing market by systems 2015-2020 ($ millions)
Exhibit 08: PEST analysis: Global HPV testing market by systems
Exhibit 09: Market overview: Global HPV testing market by consumables
Exhibit 10: Global HPV testing market by consumables 2015-2020 ($ millions)
Exhibit 11: PEST analysis: Global HPV testing market by consumables
Exhibit 12: Global HPV testing market by end-users 2015
Exhibit 13: Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions)
Exhibit 14: Global HPV testing market by geography in 2015 and 2020 ($ millions)
Exhibit 15: Americas: Market overview of HPV testing
Exhibit 16: Comparative percentage of women aged between 20 and 69 who Participated in cervical cancer screening in Americas (2003 and 2013)
Exhibit 17: HPV testing market in Americas 2015-2020 ($ millions)
Exhibit 18: HPV testing market in Americas: Analysis in various countries
Exhibit 19: Key takeaway: HPV testing market in the US
Exhibit 20: PEST analysis: HPV testing market in the US
Exhibit 21: Differences: HPV testing guidelines for cervical cancer testing
Exhibit 22: EMEA: market overview of HPV testing
Exhibit 23: Percentage of women aged 20-69 Participated in cervical cancer screening in EMEA in different countries (2003 and 2013)
Exhibit 24: HPV testing market in EMEA 2015-2020 ($ millions)
Exhibit 25: HPV testing market in EMEA: Analysis in various countries
Exhibit 26: Key takeaway: HPV testing market in the UK
Exhibit 27: PEST analysis: HPV testing market in the UK
Exhibit 28: APAC: market overview of HPV testing
Exhibit 29: HPV testing market in APAC 2015-2020 ($ millions)
Exhibit 30: HPV testing market in EMEA: Analysis in various countries
Exhibit 31: Estimated number of cervical cancer in women at different age groups 2014
Exhibit 32: Market impact analysis: HPV home-testing kits
Exhibit 33: Impact of drivers
Exhibit 34: Lack of uniformity in cervical cancer screening intervals in EMEA
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Market impact analysis: companies in key market
Exhibit 37: Market analysis: Companies focusing on mRNA HPV test
Exhibit 38: Competitive structure analysis of global HPV testing market 2015
Exhibit 39: Competitive landscape analysis of global HPV testing market 2015
Exhibit 40: Market penetration of various HPV testing manufacturing companies in global (2015)
Exhibit 41: Game changing factors for companies to focus on the market
Exhibit 42: Abbott Laboratories strength assessment
Exhibit 43: Abbott Laboratories strategy assessment
Exhibit 44: Abbott Laboratories opportunity assessment
Exhibit 45: BD strength assessment
Exhibit 46: BD strategy assessment
Exhibit 47: BD opportunity assessment
Exhibit 48: Roche Diagnostics strength assessment
Exhibit 49: Roche Diagnostics strategy assessment
Exhibit 50: Roche Diagnostics opportunity assessment
Exhibit 51: Qiagen strength assessment
Exhibit 52: Qiagen strategy assessment
Exhibit 53: Qiagen opportunity assessment
Exhibit 54: Hologic strength assessment
Exhibit 55: Hologic strategy assessment
Exhibit 56: Hologic opportunity assessment
Exhibit 57: Other prominent vendors
Exhibit 58: Product matrix: HPV testing market analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BD
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • IncellDx
  • MORE
Global HPV Testing Market 2016-2020

Key players in the global HPV testing market: Abbott Laboratories, BD, Roche Diagnostics, and Qiagen

Other Prominent Vendors in the market are: Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, and Trovagene

Commenting on the report, an analyst from the team said: “HPV and Pap tests help to detect cervical cancer in women. The Pap test identifies changes in cervical cells caused by HPV infection. The HPV test is used to check for HPV genotypes in sample cells. A physician may advise a patient to undergo both HPV and Pap tests for the screening of cervical cancer. The American Cancer Society, the US Preventive Services Task Force, the American Society for Clinical Pathology, and the American Society for Colposcopy and Cervical Pathology have provided guidelines for the testing of cervical cancer in women in the US. These guidelines state that women aged 30-65 years should undergo Pap and HPV co-testing every five years or undergo Pap test every three years.”

According to the report, vendors in the market have developed innovative home-based products that provide quick and accurate test results. This can help to reduce the cost burden on patients and keep cervical cancer at bay. The adoption of HPV home testing kits is growing developing countries owing to increasing awareness, which is striving the market growth.

Further, the report states that HPV screening test is adopted by many healthcare centers as it can predict the risk of cervical cancer. The result can be positive or negative. If positive, then the individual has to undergo Pap test or colposcopy. Through Pap test, the physician can understand the presence of abnormal or precancerous cells in the cervix. HPV test is a better predictor of low cervical cancer risk; however Pap test can be more efficient in those cases. Based on sensitivity and specificity, Pap test is adopted more than HPV testing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen
  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • DAAN Gene
  • DiaCarta
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • Genera Biosystems
  • IncellDx
  • OralDNA Labs
  • Seegene
  • SoloPap
  • Trovagene.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll